HKSE - Delayed Quote HKD

Nanjing Sinolife United Company Limited (3332.HK)

0.475
+0.070
+(17.28%)
At close: 2:04:51 PM GMT+8
Loading Chart for 3332.HK
  • Previous Close 0.405
  • Open 0.480
  • Bid 0.430 x --
  • Ask 0.475 x --
  • Day's Range 0.480 - 0.480
  • 52 Week Range 0.350 - 0.930
  • Volume 18,000
  • Avg. Volume 67,796
  • Market Cap (intraday) 449.492M
  • Beta (5Y Monthly) 0.30
  • PE Ratio (TTM) 11.88
  • EPS (TTM) 0.040
  • Earnings Date Mar 26, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jun 17, 2016
  • 1y Target Est --

Nanjing Sinolife United Company Limited, an investment holding company, engages in the manufacture and sale of nutritional supplements in the People's Republic of China, Australia, New Zealand, and internationally. It manufactures and sells cosmetics and skin care products; and trades in and retails packaged health food products, as well as leases industrial properties. The company offers its products under the Good Health, Zhongsheng, Pannex, and Cobayer series through a network of retail stores. It sells its products through distributors and e-commerce platforms; and chain pharmacies, health goods supermarkets, and tourist souvenir shops. Nanjing Sinolife United Company Limited was incorporated in 1999 and is headquartered in Nanjing, China.

www.zs-united.com

468

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 3332.HK

View More

Performance Overview: 3332.HK

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

3332.HK
12.04%
HANG SENG INDEX (^HSI)
14.00%

1-Year Return

3332.HK
2.06%
HANG SENG INDEX (^HSI)
23.36%

3-Year Return

3332.HK
227.59%
HANG SENG INDEX (^HSI)
14.33%

5-Year Return

3332.HK
259.85%
HANG SENG INDEX (^HSI)
5.62%

Compare To: 3332.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 3332.HK

View More

Valuation Measures

Annual
As of 5/8/2025
  • Market Cap

    383.25M

  • Enterprise Value

    307.40M

  • Trailing P/E

    10.33

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.48

  • Price/Book (mrq)

    0.91

  • Enterprise Value/Revenue

    0.38

  • Enterprise Value/EBITDA

    4.89

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.62%

  • Return on Assets (ttm)

    4.64%

  • Return on Equity (ttm)

    8.95%

  • Revenue (ttm)

    747.9M

  • Net Income Avi to Common (ttm)

    34.56M

  • Diluted EPS (ttm)

    0.040

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    109.11M

  • Total Debt/Equity (mrq)

    8.60%

  • Levered Free Cash Flow (ttm)

    -10.5M

Research Analysis: 3332.HK

View More

Company Insights: 3332.HK

Research Reports: 3332.HK

View More

People Also Watch